<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Acquisitions on FinanClub</title>
    <link>https://finan.club/tags/acquisitions/</link>
    <description>Recent content in Acquisitions on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Mon, 15 Jan 2024 09:02:23 +0000</lastBuildDate><atom:link href="https://finan.club/tags/acquisitions/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>IMGN</title>
      <link>https://finan.club/us/imgn/</link>
      <pubDate>Mon, 15 Jan 2024 09:02:23 +0000</pubDate>
      
      <guid>https://finan.club/us/imgn/</guid>
      <description>score:162
Chances: ImmunoGen (IMGN) has seen solid earnings estimate revision activity over the past two months. ImmunoGen might move higher on growing optimism about its earnings prospects. ImmunoGen and other stocks have been added to the Zacks Rank #1 (Strong Buy) List. ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).</description>
    </item>
    
  </channel>
</rss>
